HEMOXMOD Trademark

Trademark Overview

On Thursday, December 14, 2017, a trademark application was filed for HEMOXMOD with the United States Patent and Trademark Office. The USPTO has given the HEMOXMOD trademark a serial number of 87721045. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 2, 2021. This trademark is owned by Global Blood Therapeutics, Inc.. The HEMOXMOD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
hemoxmod

General Information

Serial Number87721045
Word MarkHEMOXMOD
Filing DateThursday, December 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 2, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 1, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hematological disorders such as sickle cell disease; pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Monday, August 2, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 2, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 6, 2021SOU EXTENSION 5 GRANTED
Tuesday, December 15, 2020SOU EXTENSION 5 FILED
Monday, January 4, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 15, 2020TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 29, 2020SOU EXTENSION 4 GRANTED
Friday, May 29, 2020SOU EXTENSION 4 FILED
Friday, May 29, 2020TEAS EXTENSION RECEIVED
Friday, December 20, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 18, 2019SOU EXTENSION 3 GRANTED
Wednesday, December 18, 2019SOU EXTENSION 3 FILED
Wednesday, December 18, 2019TEAS EXTENSION RECEIVED
Thursday, May 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 14, 2019SOU EXTENSION 2 GRANTED
Tuesday, May 14, 2019SOU EXTENSION 2 FILED
Tuesday, May 14, 2019TEAS EXTENSION RECEIVED
Friday, December 14, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2018SOU EXTENSION 1 GRANTED
Wednesday, December 12, 2018SOU EXTENSION 1 FILED
Wednesday, December 12, 2018TEAS EXTENSION RECEIVED
Tuesday, June 26, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 1, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 1, 2018PUBLISHED FOR OPPOSITION
Wednesday, April 11, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 26, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 26, 2018ASSIGNED TO EXAMINER
Thursday, December 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 18, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

hemoxmod treatment preparations pharmaceutical hypoxic conditions disease hypoxemic such hematological disorders